Agilent Technologies Inc. Stock

Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema

Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic

Agilent Expands Cross-Vendor CDS Instrument Control

Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy. Now, joint customers of Agilent Technologies and Thermo Fisher Scientific can

Agilent Compliance Services Voted No. 1 in Global Survey

Agilent Technologies Inc. (NYSE: A) today announced that the company’s ability to help laboratories comply with government regulations has been ranked second to none in a global survey.

Cell

 Agilent Technologies to Present at J.P. Morgan Healthcare Conference

Agilent Technologies Inc. (NYSE: A) today announced the following presentation will be webcast for the investor community:

What: 38th Annual J.P. Morgan Healthcare Conference

Where: The Westin

Agilent Ranked Among Top Four Best Workplaces in Greater China and Receives Certification as a Best Workplace for Women in Greater China

Agilent Technologies, Inc. (NYSE: A) today announced it has been selected as one of the top four “Best Workplaces™ in Greater China” by the Great Place to Work® (GPTW) Institute. The company has

Agilent Receives Multiple Life Science Industry Awards for Innovation

Agilent Technologies Inc. (NYSE: A) announced today that it has received two Life Science Industry Awards (LSIA) for ‘Most Innovative New Products in 2019’ from BioInformatics Inc. Since 2002, the

Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.37 billion for the fourth quarter ended Oct. 31, 2019, up 6% year over year (core⁽¹⁾ growth of 4%).

On a GAAP basis

Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)

Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for use in HNSCC in the European Union.

The assay is CE-IVD–marked as an aid in

Agilent Announces Applications Open for LabCentral Golden Ticket

Agilent Technologies Inc. (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and

Agilent Technologies Increases Cash Dividend to 18 Cents Per Share

Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 18 cents per share of common stock, reflecting a 10 percent

Agilent Announces New ICP-OES Systems with Innovative Instrument Intelligence

Agilent Technologies Inc. (NYSE: A) today announced a new generation of ICP-OES systems for laboratories serving the environmental, food, energy, chemicals, and materials markets.

The new Agilent

Agilent Named One of Top 10 Best Workplaces in Singapore

Agilent Technologies, Inc. (NYSE: A) today announced it has been named among the top 10 Best Workplaces™ in Singapore for 2019 by the Great Place to Work® (GPTW) Institute. Agilent was selected as

CORRECTING and REPLACING Agilent Technologies to Host Conference Call to Review Fourth Quarter Fiscal Year 2019 Financial Results; Announces Schedule for Upcoming Webcasts

In release dated November 4, 2019, the Piper Jaffray Conference webcast date should read: December 4 (instead of December 3), and the Evercore webcast date should read: December 5 (instead of